Roger Sidhu
CIK 1884115 · View on SEC EDGAR ↗
First SEC filing: July 8, 2025 · Latest: July 8, 2025
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 20, 2022 | ERNAW | M | 20,163 | — | — | 60,487 Direct | -25.00% | Disposed | (price as of 2026-08-20) |
| Sept. 20, 2022 | ERNAW | M | 20,163 | — | — | 20,163 Direct | — | Acquired | (price as of 2026-08-20) |
| March 11, 2022 | ERNAW | A | 142,100 | — | — | 142,100 Direct | — | Acquired | (price as of 2026-08-20) |
| March 11, 2022 | ERNAW | A | 142,100 | — | — | 142,100 Direct | — | Acquired | (price as of 2026-08-20) |
| Sept. 20, 2021 | ERNAW | A | 80,650 | — | — | 80,650 Direct | — | Acquired | (price as of 2026-08-20) |
| Sept. 20, 2021 | ERNAW | A | 161,300 | — | — | 161,300 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Sept. 20, 2022 | ERNAW | Restricted Stock Units | Common Stock (20,163) | — | — | 20,163 | Disposed |
| March 11, 2022 | ERNAW | Stock Option (Right to buy) | Common Stock (142,100) | $1.93 | March 11, 2032 | 142,100 | Acquired |
| March 11, 2022 | ERNAW | Stock Option (Right to buy) | Common Stock (142,100) | $1.93 | March 11, 2032 | 142,100 | Acquired |
| Sept. 20, 2021 | ERNAW | Restricted Stock Unit | Common Stock (80,650) | — | Sept. 20, 2031 | 80,650 | Acquired |
| Sept. 20, 2021 | ERNAW | Stock Option | Common Stock (161,300) | $9.96 | Sept. 20, 2031 | 161,300 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 8, 2025 | CRDF | Employee Stock Option (right to buy)→ Common Stock (600,000) | 600,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
ERNAW
Former Chief Medical Officer(9)| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | $447,200 | — | — | — | — | — | — | $927,472 |
| 2021 | $127,045 | — | — | — | $48,277 | — | — | $2,464,727 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $279,370 | — | — | $1,920,275 | $74,160 | — | — | $2,273,805 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.